Moderna submits regulatory application to EMA for updated COVID vaccine Ruchika Sharma3 July 2023 4:28 PM ISTCambridge: Moderna, Inc., a biotechnology company, today announced that it has submitted a regulatory application to the European Medicines Agency...
Novartis to divest 'front of eye' ophthalmology assets to Bausch + Lomb for up to 2.5 billion Ruchika Sharma3 July 2023 3:30 PM ISTNovartis will continue to supply Xiidra to patients on behalf of Bausch + Lomb, via transitional agreements for a limited period post-close, to ensure...
First trial over heartburn drug Zantac cancer claims expected in November Ruchika Sharma3 July 2023 2:30 PM ISTNew York: The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state...
Ajanta Pharma looks to expand ops in high-growth Asian, African geographies Ruchika Sharma3 July 2023 1:30 PM IST"We plan to ramp up our presence in these markets and add value to the patients' choices through our differentiated product portfolio," the drug firm...
Granules India completes USFDA audit at Visakhapatnam facility with zero 483 observations Ruchika Sharma3 July 2023 12:30 PM ISTHyderabad: Granules India Limited, a vertically integrated pharmaceutical company, has completed the U.S. Food and Drug Administration’s (US FDA)...
Zydus Lifesciences gets EIR from USFDA for Pharmez facility Ruchika Sharma3 July 2023 11:44 AM ISTAhmedabad: Zydus Lifesciences has recently announced thatthe Company has received the Establishment Inspection Report (EIR) from the United States...
CDSCO Panel Approves Sanofi's Protocol Amendment Proposal for SAR443122 Dr. Divya Colin2 July 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
CDSCO Panel Approves Roche's Protocol Amendment Proposal to Study Polatuzumab Vedotin Dr. Divya Colin2 July 2023 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has approved the protocol amendment...
Eli Lilly to buy Sigilon Therapeutics Ruchika Sharma2 July 2023 1:00 PM ISTIndianapolis: Eli Lilly and Companyand Sigilon Therapeutics, Inc. have announced a definitive agreement for Lilly to acquire Sigilon, a...
Bayer announces positive results from phase I trial of Bemdaneprocel to treat Parkinson's disease Ruchika Sharma2 July 2023 11:30 AM ISTBemdaneprocel, an investigational therapy comprised of dopamine producing neurons derived from pluripotent stem cells, is surgically implanted into...
Translumina acquires Blue Medical Devices, Netherlands Ruchika Sharma2 July 2023 10:00 AM ISTThe acquisition shall also enable Translumina to use the patented Drug application technology of Blue Medical in other product lines in peripheral and...
Bayer Pharma Gets CDSCO Panel Nod To Update Prescribing Information of Anti-cancer Drug Darolutamide Dr. Divya Colin1 July 2023 5:30 PM ISTNew Delhi: Bayer Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
